Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
μ-opioid Receptor
100%
Receptor-interacting Protein Kinase 1 (RIPK1)
57%
Heroin
54%
Co-immunoprecipitation (co-IP)
46%
Palmitoylation
42%
Locus Coeruleus Neurons
42%
Wntless
42%
Morphine
42%
Addictive Behavior
42%
Receptor Stability
42%
Saccharin
28%
Vulnerability
28%
Cellular Proteins
21%
Locus Coeruleus
19%
D2 Receptor
14%
Saline Control
14%
Protein Expression
14%
Individual Vulnerability
14%
Drug-induced
14%
No Significant Difference
14%
Early Intervention
14%
Drug Intake
14%
Motivation
14%
NCS-1
14%
Self-administration Model
14%
Disease Progression
14%
Beta-catenin
14%
G Protein-coupled Receptor
10%
Agonist Drugs
10%
Opioid Agonist
10%
Analgesic
10%
Protein of Interest
10%
Magnetic Beads
10%
Clinically Significant
10%
Chemical Probes
10%
Opiates
7%
Adaptation
7%
Enkephalin
7%
Neuroscience
μ-Opioid Receptor
57%
Heroin
54%
Behavior (Neuroscience)
42%
Locus Coeruleus
42%
Morphine
42%
Physical Dependence
18%
Opiate
15%
Receptor
14%
Individual Differences
14%
Catenin
14%
Protein Expression
14%
Enkephalin
7%
Norepinephrine
7%
Biochemistry, Genetics and Molecular Biology
Dopamine Receptor D2
42%
C-Terminus
42%
Palmitoylation
42%
Cysteine
7%